(Q50538825)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Ignacio López

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Encarnación Rodríguez-Ortiz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yolanda Almadén

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Fátima Guerrero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Montes de Oca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Carmen Pineda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Vicky Shalhoub

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Escolástico Aguilera-Tejero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

27 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

475-482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21525854%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2011.107

29 January 2020

exact match

0 references

cites work

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

FGF23-parathyroid interaction: implications in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

FGF23: its role in renal bone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Pathogenic role of Fgf23 in Hyp mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Regulation of fibroblast growth factor-23 signaling by klotho

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

FGF23 fails to inhibit uremic parathyroid glands

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Parathyroid removal prevents the progression of chronic renal failure induced by high protein diet

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Influence of parathyroidectomy, 1,25-dihydroxyvitamin D3 and high dietary calcium intake on demineralized bone matrix powder-induced bone formation in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

The PTH-calcium relationship during a range of infused PTH doses in the parathyroidectomized rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Role of the vitamin D receptor in FGF23 action on phosphate metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021

Aluminum administration in the rat separately affects the osteoblast and bone mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.107

7 January 2021